Key result
Antihypertensive drug therapies influence the risk of exacerbations, hospitalizations, and adverse pulmonary outcomes in patients with chronic obstructive pulmonary disease.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
This review considers recent evidence concerning hypertension management in patients with chronic obstructive pulmonary disease, including the effects of antihypertensive-drug classes on exacerbations, hospitalizations, and adverse pulmonary outcomes.
No takes yet. Share an insight, caveat, or question.
Finks et al. (2020) studied this question. Antihypertensive drug therapies influence the risk of exacerbations, hospitalizations, and adverse pulmonary outcomes in patients with chronic obstructive pulmonary disease.
Synapse has enriched 10 related papers. Consider them for comparative context: